The company inaugurated the new production line at the Bengaluru facility to manufacture Computed Tomography Scanners
It is one of the 15 medical device manufacturers approved under the government’s PLI scheme
A total of 21 applicants have been approved for 49 products, with the potential to utilize an incentive amount of Rs. 2541 crore
With the implementation of this project, a total of 1,030 acres of cultivable land can be irrigated per crop cycle
The bulk drug plants that have already been commissioned include CDA, para amino phenol, atorvastatin, sulfadiazine, oxcarbazepine, levofloxacin, carbidopa and levodopa
The proposed scheme to include low-income NRIs under Ayushman Bharat (PM-JAY) would ensure life-long coverage for each individual along with their spouses
Under this scheme, the company will make a committed investment in plant and machinery, get incentives on incremental sales of pharmaceutical products
Approvals accorded under Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/ drug intermediates and Active Pharmaceutical Ingredients (APIs
The setting up of these 8 plants will lead to a total committed investment of Rs. 260.40 crore
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
Subscribe To Our Newsletter & Stay Updated
